(Journal of Leukocyte Biology. 2000;68:360-365.)
© 2000
by Society for Leukocyte Biology
Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages
Phillip D. Smith*,
,
Gang Meng*,
Marty T. Sellers
,
Tina S. Rogers
and
George M. Shaw||
Departments of Medicine (
* Gastroenterology and
Rheumatology) and Surgery (
Transplantation), University of Alabama at Birmingham;
Birmingham Veterans Affairs Medical Center and the
|| Howard Hughes Medical Institute, Birmingham
Correspondence: Phillip D. Smith, M.D., Department of Medicine (Gastroenterology and Hepatology), UAB, 703 19th Street South, Birmingham, AL 35294.

ABSTRACT
Mucosal surfaces are the portal of entry for most HIV-1 infections
and
play an important role in disease pathogenesis. To characterize
the
biological parameters of HIV-1 infection in mucosal cells,
we used
purified lamina propria lymphocytes and macrophages
from normal human
small intestine to determine the distribution
of the HIV-1 receptor and
coreceptors on intestinal mononuclear
cells and the permissiveness of
these cells to HIV-1 infection.
Lamina propria lymphocytes expressed
CD4, CCR5, and CXCR4. In
contrast, lamina propria macrophages expressed
CD4 but not CCR5
or CXCR4. Intestinal lymphocytes supported replication
by R5
and X4 isolates of HIV-1, but lamina propria macrophages were
permissive
to neither. RANTES, macrophage inflammatory protein-1

(MIP-1

),
and MIP-1ß inhibited infection of intestinal lymphocytes
by
BaL, indicating that R5 infection of the intestinal lymphocytes
was
mediated by CCR5. Thus, resident lamina propria lymphocytes,
not
macrophages, are the target mononuclear cell for HIV-1 infection
in the
intestinal mucosa during early HIV-1 infection.
Key Words: mucosa lamina propria CCR5 CXCR4

INTRODUCTION
Mucosal surfaces play a fundamental role in the pathogenesis
of
HIV-1 disease [
1
]. First, the gastrointestinal tract
mucosa
is the body surface through which HIV-1 enters the host in
homosexual
and vertical transmission. During vertical transmission, the
upper
gastrointestinal tract mucosa is particularly important,
providing
the site of virus translocation after the fetus or infant
swallows
HIV-1-infected amniotic fluid
in utero, infected
blood or cervical
secretions intrapartum, or infected breast milk
postpartum [
2
].
Second, the mucosa likely participates
in the selection of the
genotypic and phenotypic minor variants that
are transmitted
in acute infections. Third, the gastrointestinal tract
mucosa
is the largest lymphoid organ in the body [
3
],
containing the
largest number of lymphocytes and macrophages of any
body organ
[
4
]. Consequently, the enteric mucosa may be
an important reservoir
for HIV-1-infected mononuclear cells
[
5
]. Moreover, the local
abundance of cytokines
[
6
] and microbial agents [
7
] capable
of
up-regulating HIV-1 expression [
8
,
9
]
suggests that the
mucosa is also a potential site of high-level HIV-1
production.
Fourth, the local and systemic immunosuppression induced by
HIV-1
infection predisposes the gastrointestinal tract to a complex
array
of opportunistic infections [
7
], resulting in
substantial morbidity
in the majority of persons who develop AIDS
[
10
].
After HIV-1 inoculated onto a mucosal surface crosses the
epithelium, likely by transcytosis [11
], it encounters
lamina propria mononuclear cells. These cells, or possibly epithelial
cells, presumably select from the pool of inoculated variants the
macrophage-tropic species that are transmitted in nearly all mucosally
acquired HIV-1 infections [12
13
14
15
]. This selection is
likely receptor-mediated, but the distribution of CD4 (the primary
receptor for HIV-1), CCR5 [the coreceptor for macrophage-tropic (R5)
viruses] and CXCR4 [the coreceptor for lymphocyte-tropic (X4)
viruses] on intestinal lamina propria cells has not been fully
elucidated. In addition, the biological parameters of HIV-1 replication
in mucosal mononuclear cells have not been fully characterized.
Therefore, to elucidate the role of mucosal mononuclear cells in HIV-1
disease, we have initiated a series of studies that seek to
characterize intestinal (lamina propria) lymphocytes and macrophages
for HIV-1 receptor and coreceptor expression and susceptibility to
infection by R5 and X4 HIV-1.

RESIDENT INTESTINAL LYMPHOCYTES AND MACROPHAGES
Current concepts regarding virological events in the mucosa
during
HIV-1 disease have been extrapolated largely from studies of
the
interaction between blood mononuclear cells and HIV-1. However,
lamina
propria lymphocytes and macrophages differ phenotypically
and
functionally in many regards from blood lymphocytes and
monocytes
[
16
,
17
]. Consequently, information
acquired from
the study of blood mononuclear cells and HIV-1 does not
accurately
reflect mucosal cell-HIV-1 events. Therefore, to study the
interaction
between primary mucosal cells and HIV-1, we developed a
technique
to isolate and purify lamina propria lymphocytes and
macrophages
from normal human small intestinal mucosa. Lamina propria
lymphocytes
and macrophages were isolated from jejunal tissue sections
from
organ transplantation donors without intestinal or immunological
diseases
by tissue digestion using the neutral protease Dispase
[
18
].
The lamina propria mononuclear cells were then
separated by
counterflow centrifugal elutriation into highly purified
populations
of lymphocytes and macrophages [
18
,
19
]. The intestinal lymphocytes
displayed typical
lymphocyte morphology and phenotype [
18
].
Intestinal
macrophages isolated and purified by the same technique
displayed the
size distribution, morphological features, ultrastructure,
phagocytic
activity, and phenotype of macrophages [
18
]. Blood
lymphocytes
and monocytes from the same donors were purified by
counterflow
centrifugal elutriation [
19
] and then
treated with neutral
protease according to the tissue digestion
protocol in order
for all cell populations to be treated similarly
before study.
Purified intestinal lymphocytes were routinely
95%
CD3+CD103+ and blood lymphocytes routinely
95% CD3+, and neither population contained detectable
macrophages or monocytes, respectively (Fig. 1
). Approximately 1% of intestinal lymphocytes were B cells, and
about 5% of blood lymphocytes were B cells. Conversely,
HLA-DR+CD13+ intestinal macrophages, which are
CD14- [17
, 18
], and
CD14+HLA-DR+CD13+ blood monocytes
contained no detectable lymphocytes (Fig. 1)
. The intestinal cells did
not express CD83 or display ultrastructural characteristics of
dendritic cells before or after treatment with optimal concentrations
of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor
necrosis factor
(TNF-
), and interleukin-4 (IL-4).

REDUCED PERMISSIVENESS OF INTESTINAL MACROPHAGES TO HIV-1 INFECTION
We recently showed that intestinal macrophages require 1,000-fold
more
virus to establish infection
in vitro than
monocyte-derived
macrophages (
Fig. 2
) [
20
]. This is consistent with the remarkably
low
prevalence (0.06%) of HIV-1 mRNA-expressing macrophages
among lamina
propria mononuclear cells in the gastrointestinal
tract mucosa of
patients with AIDS [
5
]. The marked reduction
in the
permissiveness of intestinal macrophages to HIV-1 infection
was not
caused by the isolation procedure or reduced CD4 expression.
Instead,
intestinal macrophages expressed almost no detectable
CCR5 (
Fig. 3A
), the principal coreceptor for R5 (macrophage-tropic)
viruses,
although both intestinal macrophages and blood monocytes
contained
comparable levels of CCR5 mRNA
(Fig. 3B)
. Exposure
of monocyte-derived
macrophages to HIV-1 or gp120 lead to increased
surface expression of
CCR5, but exposure of intestinal macrophages
to either HIV-1 or gp120
did not
(Fig. 3C)
. These findings
suggested that the markedly impaired
permissiveness of intestinal
macrophages to HIV-1 was due to the near
absence of macrophage
surface CCR5.
The findings also suggested a paradox in which intestinal
macrophages
are down-regulated for permissiveness to HIV-1
[
20
], yet acutely
transmitted HIV-1 species are nearly
always macrophage-tropic
[
12
13
14
15
]. Therefore, to confirm
the absence of CCR5 on
intestinal macrophages and to elucidate the
potential role of
intestinal lymphocytes in early HIV-1 infection, we
characterized
purified primary intestinal lymphocytes and macrophages
from
the same donors for surface CD4, CCR5, and CXCR4 expression
and
then determined the permissiveness of the cells to macrophage-tropic
and
lymphocyte-tropic HIV-1.

INTESTINAL LYMPHOCYTES, NOT MACROPHAGES, EXPRESS CCR5 AND
CXCR4
Because intestinal macrophages appeared to lack CCR5, we next
investigated
primary intestinal lymphocytes for surface CCR5 and CXCR4
expression
[
21
]. Among fresh intestinal lymphocytes
purified from a representative
donor, 10% expressed surface CD4, 92%
CCR5, and 86% CXCR4 (
Fig. 4
). Among intestinal macrophages freshly isolated from the
same
donor, 9% expressed CD4, but, in sharp contrast to the
intestinal
lymphocytes, none expressed detectable CCR5 or CXCR4
(Fig. 4)
. In
addition, incubation of the macrophages with optimal
doses of M-CSF,
GM-CSF, IL-6, phorbol myristate acetate (PMA),
or lipopolysaccharide
(LPS) for 24 h did not induce expression
of either coreceptor.
Blood lymphocytes and monocytes from the
same donor expressed CD4 and
both CCR5 and CXCR4
(Fig. 4)
.
The presence of CCR5 on blood monocytes
(and on the intestinal
and blood lymphocytes) from the same donor
indicated that the
absence of surface CCR5 on intestinal macrophages
was not due
to expression of the

32 CCR5 deletion allele. The
frequencies
of CD4
+, CCR5
+, and
CXCR4
+ cells in populations of purified
intestinal and
unmatched blood mononuclear cells from additional
donors (
Table 1
) confirmed the presence of CCR5 and CXCR4 on
each cell type except
the intestinal macrophages.

INTESTINAL LYMPHOCYTES, NOT MACROPHAGES, SUPPORT R5 AND X4
HIV-1 REPLICATION
Having shown that intestinal lymphocytes express CD4, CCR5,
and
CXCR4 and that intestinal macrophages express only CD4,
we next
investigated the susceptibility of these populations
to HIV-1 infection
[
21
]. Intestinal lymphocytes (cultured 2
days with
phytohemagglutinin 5 µg/mL and IL-2 24 U/mL)
and macrophages
(cultured 5 days in M-CSF 1,000 U/mL) were inoculated
in parallel with
R5 (BaL) and X4 (IIIB) isolates of HIV-1 (TCID
50 10,000
each). Intestinal lymphocytes supported replication by
both BaL and
IIIB (
Fig. 5
,
left), consistent with their
CCR5
+CXCR4
+ phenotype. In contrast, intestinal
macrophages, which displayed
no detectable CCR5 or CXCR4, were
permissive to neither BaL
nor IIIB (
Fig. 5
, left). Intestinal
macrophages also did not
support replication by additional R5
laboratory isolates (ADA
and DJV; TCID
50 10,000) and
primary clinical isolates (MDR 24
and JOEL; TCID
50 500;
Fig. 6
). Furthermore, culturing the macrophages
with GM-CSF, TNF-

,
IL-6, PMA, or LPS during or after exposure
of the cells to HIV-1 did
not result in detectable p24 production.
We next compared the level of HIV-1 replication in intestinal
mononuclear
cells with that of blood lymphocytes and monocyte-derived
macrophages
from the same donor. Similar to the intestinal lymphocytes,
blood
lymphocytes (cultured in the same conditions as the intestinal
lymphocytes)
supported HIV-1 replication by BaL and IIIB (
Fig. 5
,
right).
Although intestinal lymphocytes were permissive to HIV-1, they
produced
less p24 antigen than infected blood lymphocytes. In sharp
contrast,
monocyte-derived macrophages inoculated with BaL produced
high
levels of p24 (peak 90,000 pg/mL), whereas intestinal macrophages
inoculated
with the same doses of HIV-1 produced no detectable p24
(
Fig. 5 , right). Neither intestinal macrophages nor monocyte-derived
macrophages
supported IIIB replication, consistent with the absence of
CXCR4
on the intestinal macrophages (
Fig. 4
;
Table 1
) and the lack
of
biological function of the CXCR4 receptor on blood monocytes
[
22
].
Thus, intestinal lymphocytes, not macrophages,
support HIV-1
replication.

SUMMARY
The results summarized above suggest the following sequence
of
events in the intestinal mucosa before and during early HIV-1
infection.
As circulating CCR5
+CXCR4
+ blood
lymphocytes and monocytes traffic
through the mucosa, they encounter
local chemotactic signals
that direct their migration into the lamina
propria. Once in
the mucosa, the cells encounter local bacterial
products, such
as LPS. The LPS binds to monocyte surface CD14, the
receptor
for complexes of LPS and LPS-binding protein, which activates
the
cells and causes down-regulation of CCR5 expression
[
23
]. Lymphocytes,
lacking CD14, would not be
susceptible to the down-modulatory
action of LPS. Also, differentiation
of blood monocytes into
macrophages may cause down-regulation of
surface CXCR4 [
24
],
offering a potential explanation, at
least in part, for the
impaired expression of CXCR4 on the macrophages.
Whether human
small intestinal macrophages differ from colonic
macrophages
in the expression of surface CCR5 and CXCR4 is not known.
As
the monocytes take up residence in the lamina propria and
differentiate
into macrophages, they also lose surface CD14 by
mechanisms
that are currently under investigation [
17
].
After HIV-1 inoculated onto a mucosal surface crosses the epithelium,
it encounters CD4+ mononuclear cells in the underlying
lamina propria. Whereas intestinal macrophages were presumed to be the
initial target cell for R5 HIV-1 entry, the findings presented above
indicate that the only resident mononuclear cells capable of supporting
R5 viral replication in the mucosa are lamina propria lymphocytes, not
macrophages. Although dendritic cells play an important role in the
pathogenesis of early HIV-1 infection in extraintestinal lymphoid
tissue [25
, 26
], their role in intestinal
HIV-1 infection is less likely since, as shown here, they appear not to
be present in intestinal lamina propria. Dendritic cells are present in
organized lymphoid structures (i.e., Peyers patches) of the mouse
small intestine [27
], but such structures are uncommon
in the proximal small intestine of humans. Thus, the presence of CCR5
on intestinal lymphocytes and their susceptibility to R5 virus
infection suggest that after initial selection, possibly by intestinal
epithelial cells, the R5 species that enters the lamina propria first
infects lymphocytes.
That intestinal lymphocytes, not macrophages, are permissive to HIV-1
infection is consistent with in vivo observations in both
humans and macaques. As we have shown in humans with AIDS, mucosal
macrophages productively infected with HIV-1 are rare, with a
prevalence of 0.06% among lamina propria mononuclear cells
[5
]. In addition, the majority of cells containing HIV-1
mRNA in nongastrointestinal lymphoid tissue (e.g., tonsils) are not
macrophages but other lymphoid mononuclear cells [28
].
In macaques, simian immunodeficiency virus (SIV) inoculated
intravenously [29
], intravaginally [30
],
and orally [31
] first infects mucosal lymphocytes and
the subsequent local replication occurs predominantly in lymphocytes;
infected intestinal macrophages are rare during early infection
[29
30
31
]. Also, CCR5+ macrophages constitute
<1% of rectal lamina propria macrophages in macaques
[32
].
Thus, taken together, these findings indicate that resident macrophages
play a less important role in the pathogenesis of early mucosal HIV-1
infection than previously suspected. Instead, intestinal lymphocytes
appear to be the initial target cell for mucosally acquired R5 HIV-1
and the predominant source of HIV-1 production among resident
mononuclear cells in the gastrointestinal tract mucosa.

ACKNOWLEDGEMENTS
This study was supported by National Institutes of Health grants
DK-47322,
AI-41530, DE-72621, and by the Research Service of the
Department
of Veterans Affairs.

REFERENCES
1
- Smith, P. D., Wahl, P. D. (1999) Immunobiology of mucosal HIV-1 infection Ogra, P. R. Lamm, M. E. Bienenstock, J. Mestecky, J. Strober, W. McGhee, J. R. eds. Mucosal Immunology ,977 Academic San Diego.
2
- Li, L., Smith, P. D. (1996) Immunobiology of mucosal HIV-1 infection Curr. Op. Gastroenterol. 12,560-563
3
- Brandtzaeg, P. (1989) Overview of the mucosal immune system Curr. Top. Microbiol. Immunol. 146,13-25[Medline]
4
- Lee, S. H., Starkey, P. M., Gordon, S. (1984) Quantitative analysis of total macrophage content in adult mouse tissues: immunochemical studies with monoclonal antibody F4/80 J. Exp. Med. 161,475-489[Abstract/Free Full Text]
5
- Smith, P. D., Fox, C. H., Masur, H., Winter, H. S., Alling, D. W. (1994) Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type-1 RNA in esophageal mucosa J. Exp. Med. 180,1541-1546[Abstract/Free Full Text]
6
- Smith, P. D., Saini, S. S., Raffeld, M., Manischewitz, J. F., Wahl, S. M. (1992) Cytomegalovirus induces expression of tumor necrosis factor by human monocytes and mucosal macrophages J. Clin. Invest. 90,1642-1648
7
- Smith, P. D. (1995) Intestinal infections in HIV-1 disease Blaser, M. J. Smith, P. D. Ravdin, J. I. Greenberg, H. B. Guerrant, R. L. eds. Infections of the Gastrointestinal Tract ,483 Raven New York.
8
- Peterson, P. K., Gekker, G., Chao, C. C., Hu, S., Edelman, C., Balfour, H. H., Verhoef, J. (1992) Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-
-mediated mechanism J. Clin. Invest. 89,574-580
9
- Orenstein, J. M., Fox, C., Wahl, S. M. (1998) Macrophages as a source of HIV during opportunistic infections Science 276,1857-1861[Abstract/Free Full Text]
10
- Smith, P. D., Wilcox, C. M. (1999) Gastrointestinal complications of the acquired immunodeficiency syndrome Yamada, T. Alpers, D. H. Owyang, C. Powell, D. W. Laine, L. eds. Texrtbook of Gastroenterology ,2400 Lippincott Williams & Wilkins Philadelphia, PA.
11
- Bomsel, M. (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier Nat. Med. 3,42-47[Medline]
12
- Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., Ho, D. D. (1993) Genotypic and phenotypic characterization of HIV-1 in patients with primary infection Science 261,1179-1181
13
- McNearney, T., Hornickova, Z., Markham, R., Birdwell, A., Arens, M., Saah, A., Ratner, L. (1992) Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease Proc. Natl. Acad. Sci. USA 89,10247-10251[Abstract/Free Full Text]
14
- Wolinsky, S. M., Wike, C. M., Korber, B. T. M., Hutto, C., Parks, W. P., Rosenblum, L. L., Kunstman, K. J., Furtado, M. R., Munoz, J. L. (1992) Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants Science 255,1134-1136[Abstract/Free Full Text]
15
- vant Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A., Albrecht-van Lent, N., Scherpbier, H. J., Veestra, J., Boer, K., Coutinho, R. A., Miedema, F., Schuitemaker, H. (1994) Macrophage-tropic variants initiate human immunodeficiency virus type I infection after sexual, parenteral, and vertical transmission J. Clin. Invest. 94,2060-2067
16
- Hurst, S. D., Coooper, C. J., Sitterding, S. M., Choi, J.-h., Jump, R. L., Levine, A. D., Barrett, T. A. (1999) The differentiated state of intestinal lamina porpria CD4+ T cells results in altered cytokine production, activation threshold and costimulatory requirements J. Immunol. 163,5937-5945[Abstract/Free Full Text]
17
- Smith, P. D., Mosteller-Barnum, M., Smythies,
L. E., Sibley, D., Russell, M., Merger, M., Graham, M. F.,
Shimada, T., Kubagawa, H. (2000) Intestinal macrophages lack CD14 and
CD89 and consequently are down-regulated for LPS- and IgA-mediated
activities. J. Immunol. In press.
18
- Smith, P. D., Janoff, E. N., Mosteller-Barnum, M., Merger, M., Orenstein, J. M., Kearney, J. F., Graham, M. F. (1997) Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine J. Immunol. Meth. 202,1-11[Medline]
19
- Wahl, L. M., Smith, P. D. (1991) Isolation of macrophages/monocytes from human peripheral blood and tissues Coligan, J. E. Kruisbeek, A. M. Marguilies, D. H. Shevach, E. M. Strober, W. eds. Current Protocols in Immunology 1,7.6.1-7.6.8 New York.
20
- Li, L., Meng, G., Graham, M. F., Shaw, G. M., Smith, P. D. (1999) Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5 Gastroenterology 116,1043-1053[Medline]
21
- Meng, G., Sellers, M. T., Mosteller-Barnum,
M., Rogers, T. S., Shaw, G. M., Smith, P. D. (2000)
Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and
are the primary target cell for HIV-1 in the intestinal mucosa. J. Infect. Dis. In press.
22
- Lapham, C. K., Zaitseva, M. B., Lee, S., Romanstseva, T., Golding, H. (1999) Fusion of monocytes and macrophges with HIV-1 correlates with biochemical properties of CXCR4 and CCR5 Nat. Med. 5,303-308[Medline]
23
- Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N. C., Luini, W., Polentarutti, N., Sozzani, S., Mantovani, A. (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes J. Exp. Med. 185,969-974[Abstract/Free Full Text]
24
- di Marzio, P., Tse, J., Landau, N. R. (1998) Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophges AIDS Res. Hum. Retrovir. 14,129-138[Medline]
25
- Frankel, S. S., Wenig, B. M., Burke, A. P., Mannan, P., Thompson, L. D. R., Abbondanzo, S. L., Nelson, A. M., Pope, M., Steinman, R. M. (1996) Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid Science 72,115-117
26
- Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z.-Q., Dailey, P. J., Balfour, H. H., Erice, A., Perelson, A. S. (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue Science 274,985-989[Abstract/Free Full Text]
27
- Kelsall, B. L., Strober, W. (1996) Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyers patch J. Exp. Med. 183,237-247[Abstract/Free Full Text]
28
- Cavert, W., Notermans, D. W., Staskus, K., Wietgrete, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z-Q., Mills, R., McDade, H., Goudsmit, J., Danner, S. A., Haase, A. T. (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection Science 276,960-965[Abstract/Free Full Text]
29
- Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., Lackner, A. A. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 280,427-431[Abstract/Free Full Text]
30
- Zhang, Z.-Q., Schuler, T., Zupancic, M., Wietgrefe, S., Staskus, K. A., Reimann, K. A., Reinhart, T. A., Rogan, M., Cavert, W., Miller, C. J., Veazey, R. S., Notermans, D., Little, S., Dannear, S. A., Richman, D. D., Havlir, D., Wong, J., Jordan, H. L., Schacker, T. W., Racz, P., Tenner-Racz, K., Letvin, N. L., Wolinsky, S., Haase, A. T. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells Science 286,1353-1357[Abstract/Free Full Text]
31
- Stahl-Henning, C., Steinman, R. M., Tenner-Racz, K., Pope, M., Stolte, N., Matz-Rensing, K., Grobschupff, G., Raschdorff, B., Hunsmann, G., Racz, P. (1999) Rapid infection of oral mucosa-associated lymphoid tissue with simian immunodeficiency virus Science 285,1261-1265[Abstract/Free Full Text]
32
- Zhang, L., He, T., Talal, A., Wang, G., Frankel, S. S., Ho, D. D. (1998) In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5 J. Virol. 72,5035-5045[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
M. Guadalupe, S. Sankaran, M. D. George, E. Reay, D. Verhoeven, B. L. Shacklett, J. Flamm, J. Wegelin, T. Prindiville, and S. Dandekar
Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection
J. Virol.,
August 15, 2006;
80(16):
8236 - 8247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Smith, G. Meng, J. F. Salazar-Gonzalez, and G. M. Shaw
Macrophage HIV-1 infection and the gastrointestinal tract reservoir
J. Leukoc. Biol.,
November 1, 2003;
74(5):
642 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Ketas, I. Frank, P. J. Klasse, B. M. Sullivan, J. P. Gardner, C. Spenlehauer, M. Nesin, W. C. Olson, J. P. Moore, and M. Pope
Human Immunodeficiency Virus Type 1 Attachment, Coreceptor, and Fusion Inhibitors Are Active against both Direct and trans Infection of Primary Cells
J. Virol.,
February 15, 2003;
77(4):
2762 - 2767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Montaner, C.-F. Perno, and S. Crowe
Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis
J. Leukoc. Biol.,
September 1, 2000;
68(3):
301 - 302.
[Full Text]
[PDF]
|
 |
|